Inflammatix is developing a game-changing diagnostic test that reads the immune system and uses proprietary algorithms to generate clinically actionable information.
This can distinguish bacterial or viral infection and determine the severity of infection in 30 minutes at the point of care. Faster diagnosis means more timely and appropriate therapy and level of care decisions, which enable better patient outcomes.